Company / Assets per Share
GT Biopharma, Inc. Assets per Share History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2440.73
FY2017
5-year range
$0.00 / $2440.73
FY2013-FY2017
Trend
+10847588.9%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share changed +10847589% YoY in FY2017, a notable deviation from the 6-year average annual change of +1811995%.
Based on SEC 10-K filings.
2440.73 in FY2017.
Improved from $0.38 to $2440.73 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, assets per share increased 10847588.9% year-over-year.
- Lowest assets per share in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2017 | $2440.73 | +10847588.9% |
| FY2016 | $0.02 | -94.0% |
| FY2015 | $0.38 | +24114.2% |
| FY2014 | $0.00 | +427.7% |
| FY2013 | $0.00 | -65.0% |
| FY2012 | $0.00 | -2.7% |
| FY2011 | $0.00 | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026